Skip to main content

Human papillomavirus tumour status is not associated with a positive depression screen for patients with oropharyngeal cancer

  • J R Qualliotine (a1) (a2), J A Califano (a1) (a2) (a3), R J Li (a1) (a4), D Gold (a3), B Messing (a3), G Lee (a3), P Ha (a1) (a3) (a5) and C Fakhry (a1) (a3)...
Abstract Background:

Several risk factors for depression in patients with oropharyngeal cancer have been determined. However, it is unknown whether human papillomavirus associated oropharyngeal cancer, which has a distinct clinico-demographic profile, modulates this risk.


A retrospective analysis was conducted of patients with oropharyngeal cancer. These patients had completed a 10-item depression screening questionnaire before receiving treatment for their disease from 2011 to 2014. Associations between patient or disease characteristics and depression screening questionnaire results were investigated.


The study comprised 69 patients, 31 (44.9 per cent) of whom screened positive for depression. There were no significant differences in distributions of clinico-demographic or histopathological characteristics, including human papillomavirus tumour status, by depression screen result.


This population has a high risk for depression, but no obvious risk factors, including human papillomavirus tumour status, were associated with an elevated risk. This inability to risk-stratify patients by clinico-demographic or disease characteristics emphasises the importance of regular depression screening for all patients in this population.

Corresponding author
Address for correspondence: Dr Carole Fakhry, Department of Otolaryngology – Head and Neck Surgery, 601 N Caroline Street, JHOC 6th Floor, Baltimore, MD 21287, USA Fax: +01 (410) 955 6526 E-mail:
Hide All
1 Waraich P, Goldner EM, Somers J, Hsu L. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry 2004;49:124–38
2 Krebber AM, Buffart LM, Kleijn G, Riepma IC, De Bree R, Leemans CR et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology 2014;23:121–30
3 Neilson KA, Pollard AC, Boonzaier AM, Corry J, Castle DJ, Mead KR et al. Psychological distress (depression and anxiety) in people with head and neck cancers. Med J Aust 2010;193:S4851
4 Kugaya A, Akechi T, Okuyama T, Nakano T, Mikami I, Okamura H et al. Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer 2000;88:2817–23
5 Barber B, Dergousoff J, Nesbitt M, Mitchell N, Harris J, O'Connell D et al. Depression as a predictor of postoperative functional performance status (PFPS) and treatment adherence in head and neck cancer patients: a prospective study. J Otolaryngol Head Neck Surg 2015;44:38
6 Kim S-A, Roh J-L, Lee S-A, Lee S, Kim S-B, Choi S-H et al. Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer. Cancer 2016;122:131–40
7 Hammerlid E, Silander E, Hörnestam L, Sullivan M. Health-related quality of life three years after diagnosis of head and neck cancer--a longitudinal study. Head Neck 2001;23:113–25
8 Hall RC, Wise MG. The clinical and financial burden of mood disorders. Cost and outcome. Psychosomatics 1995;36:S1118
9 Beck D, Koenig H. Minor depression: a review of the literature. Int J Psychiatry Med 1996;26:177209
10 Yu GP, Mehta V, Branovan D, Huang Q, Schantz S. Non-cancer-related deaths from suicide, cardiovascular disease, and pneumonia in patients with oral cavity and oropharyngeal squamous carcinoma. Arch Otolaryngol Head Neck Surg 2012;138:2532
11 Barber B, Dergousoff J, Slater L, Harris J, O'Connell D, El-Hakim H et al. Depression and survival in patients with head and neck cancer. JAMA Otolaryngol Neck Surg 2016;142:284–8
12 Newport DJ, Nemeroff CB. Review, assessment and treatment of depression in the cancer patient. J Psychosom Res 1998;45:215–37
13 Söllner W, DeVries A, Steixner E, Lukas P, Sprinzl G, Rumpold G et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer 2001;84:179–85
14 Vodermaier A, Linden W, Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst 2009;101:1464–88
15 Hirschfeld R, Weissman M. Risk factors for major depression and bipolar disorder. In: Davis KL, Charney D, Coyle JT, Nemeroff C, eds. Neuropsychopharmacology. Philadelphia: Lippincott, Williams & Wilkins, 2002;1018–25
16 Katz MR, Irish JC, Devins GM, Rodin GM, Gullane PJ. Psychosocial adjustment in head and neck cancer: the impact of disfigurement, gender and social support. Head Neck 2003;25:103–12
17 Haisfield-Wolfe ME, McGuire DB, Soeken K, Geiger-Brown J, De Forge BR. Prevalence and correlates of depression among patients with head and neck cancer: a systematic review of implications for research. Oncol Nurs Forum 2009;36:E10725
18 Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008;100:407–20
19 Baxi SS, Shuman AG, Corner GW, Shuk E, Sherman EJ, Elkin EB et al. Sharing a diagnosis of HPV-related head and neck cancer: the emotions, the confusion, and what patients want to know. Head Neck 2013;35:1534–41
20 Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. Pharynx. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual, 7th edn. New York: Springer, 2010;4156
21 Begum S, Gillison ML, Ansari-Lari MA, Shah K, Westra WH. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res 2003;9:6469–75
22 Eaton WW, Muntaner C, Smith C, Tien A, Ybarra M. Center for Epidemiologic Studies Depression Scale: Review and revision (CESD and CESD-R). In: Maruish ME, ed. The Use of Psychological Testing for Treatment Planning and Outcomes Assessment, 3rd edn. Mahwah, New Jersey: Lawrence Erlbaum, 2004;363–77
23 Irwin M, Artin KH, Oxman MN. Screening for depression in the older adult: criterion validity of the 10-item Center for Epidemiological Studies Depression Scale (CES-D). Arch Intern Med 1999;159:1701–4
24 Bjorgvinsson T, Kertz SJ, Bigda-Peyton JS, McCoy KL, Aderka IM. Psychometric properties of the CES-D-10 in a psychiatric sample. Assessment 2013;20:429–36
25 Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med 1994;10:7784
26 Tu CH, Hsu MC, Chi SC, Lin HY, Yen YC. Routine depression screening and diagnosing strategy for cancer inpatients. Psychooncology 2014;23:1057–67
27 Adachi Y, Kimura H, Sato N, Nagashima W, Nakamura K, Aleksic B et al. Preoperative level of depression is a predictor of postoperative levels of depression in patients with head and neck cancer. Jpn J Clin Oncol 2014;44:311–17
28 Neilson K, Pollard A, Boonzaier A, Corry J, Castle D, Smith D et al. A longitudinal study of distress (depression and anxiety) up to 18 months after radiotherapy for head and neck cancer. Psychooncology 2013;22:1843–8
29 Lydiatt WM, Bessette D, Schmid KK, Sayles H, Burke WJ. Prevention of depression with escitalopram in patients undergoing treatment for head and neck cancer: randomized, double-blind, placebo-controlled clinical trial. JAMA Otolaryngol Neck Surg 2013;139:678–86
30 Milbury K, Rosenthal DI, El-Naggar A, Badr H. An exploratory study of the informational and psychosocial needs of patients with human papillomavirus-associated oropharyngeal cancer. Oral Oncol 2013;49:1067–71
31 Hess CB, Rash DL, Daly ME, Farwell DG, Bishop J, Vaughan AT et al. Competing causes of death and medical comorbidities among patients with human papillomavirus-positive vs human papillomavirus-negative oropharyngeal carcinoma and impact on adherence to radiotherapy. JAMA Otolaryngol Head Neck Surg 2014;140:312–16
32 Moubayed SP, Sampalis JS, Ayad T, Guertin L, Bissada E, Gologan OE et al. Predicting depression and quality of life among long-term head and neck cancer survivors. Otolaryngol Head Neck Surg 2015;152:91–7
33 Koch R, Wittekindt C, Altendorf-Hoffmann A, Singer S, Guntinas-Lichius O. Employment pathways and work-related issues in head and neck cancer survivors. Head Neck 2015;37:585–93
34 Pinquart M, Duberstein P. Depression and cancer mortality: a meta-analysis. Psychol Med 2010;40:1797–810
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The Journal of Laryngology & Otology
  • ISSN: 0022-2151
  • EISSN: 1748-5460
  • URL: /core/journals/journal-of-laryngology-and-otology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 3
Total number of PDF views: 55 *
Loading metrics...

Abstract views

Total abstract views: 216 *
Loading metrics...

* Views captured on Cambridge Core between 19th July 2017 - 22nd February 2018. This data will be updated every 24 hours.